A better understanding of the molecular basis for immune recognition of antigens has led to the development of many new and promising approaches to the stimulation of tumour immunity. Many of these vaccines are being tested in clinical trials, and will hopefully become accepted forms of treatment for solid cancers before the next century.
展开▼
